FDA Approved: SACUBITRIL AND VALSARTAN — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original application (ANDA213748) for a generic sacubitril/valsartan combination from Novadoz Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Sacubitril and valsartan (sacubitril/valsartan)

Snippet

ORIG AP for SACUBITRIL AND VALSARTAN (SACUBITRIL AND VALSARTAN)